Beclot 500mg/250mg Tablet MR

Description

Information About Beclot 500mg/250mg Tablet MR

Beclot 500mg/250mg Tablet MR is a combination of Beclot with a dosage of 500mg, and 250mg of an additional substance. The medication known as MR is a composite pharmaceutical formulation employed for the treatment of excessive menstrual bleeding and dysmenorrhea. One potential mechanism of action is the inhibition of blood clot disintegration, which serves to regulate and mitigate the occurrence of heavy bleeding during menstrual periods. Additionally, it inhibits the synthesis of specific chemical mediators that induce nociception and inflammatory responses.

The administration of Beclot 500mg/250mg Tablet MR is not restricted to a specific time of day and can be taken with or without meals. However, it is recommended to establish a consistent daily dosing schedule for optimal therapeutic outcomes. For optimal efficacy, it is recommended to administer the treatment on the initial day of menstruation. Continue to adhere to the prescribed duration of treatment as recommended by your healthcare provider.  Administer the prescribed medication according to the dosage and time recommended by the physician. In the event of a missed dose, promptly take it upon recollection. It is imperative to adhere to the complete duration of medication, even in the event of symptom alleviation. It is advisable to notify your healthcare provider if there is a lack of observable changes in menstrual patterns for three consecutive menstrual cycles.

The prevalent adverse effects associated with this medication encompass symptoms such as nausea, abdominal discomfort, cephalalgia, nasal congestion, sinusalgia, sinusitis, cutaneous eruption, fatigue, and musculoskeletal discomfort involving the bones, muscles, or joints. The administration of this medication may potentially result in the occurrence of diarrhea. Therefore, it is advisable to consume ample amounts of fluids concurrently with the medication to mitigate the risk of dehydration. It is recommended to seek medical consultation in the event of a lack of discernible alterations in menstrual patterns over the course of three consecutive menstrual cycles.

Prior to administration, it is imperative to inform your healthcare provider of any preexisting renal impairments or disorders related to vaginal hemorrhage. It is advisable for pregnant or breastfeeding women to seek guidance from their healthcare provider prior to initiating the use of this medication. It is imperative to disclose to your healthcare provider the complete list of medications you are currently on. Patients may be required to undergo regular eye examinations while undergoing treatment with this medication. It is recommended to abstain from consuming alcohol when concurrently using this medication.

Beclot 500mg/250mg Tablet MR Uses

• Treatment of Heavy Menstrual Bleeding
• Treatment of Menstrual Pain

Beclot 500mg/250mg Tablet MR Benefits 

In Treatment of Heavy Menstrual Bleeding

Excessive menstrual bleeding is a matter of significant worry for women. The pharmaceutical formulation known as Beclot 500mg/250mg Tablet MR is a composite medication designed to alleviate the symptoms associated with excessive menstrual bleeding. The process of clotting during menstruation aids in the reduction of excessive bleeding by facilitating the coagulation of the uterine lining. It is recommended to adhere to the indicated dosage and administration instructions of the medication in order to optimize its efficacy. In addition, engaging in yoga or meditation practices can be effective in mitigating stress and redirecting cognitive focus during such periods.

Treatment of Menstrual Pain

The medication in question is a tablet containing Beclot, with a dosage of 500mg/250mg. Menstrual cramp relief (MR) alleviates pain associated with muscle cramps experienced during menstrual cycles. The mechanism of action involves the inhibition of pain signals, muscle relaxation, and the prevention of abrupt muscle contractions, commonly referred to as spasms. This intervention addresses the individual’s experience of pain and discomfort. In addition, individuals may consider utilizing a heating pad, engaging in a hot water shower, minimizing stress levels, and incorporating gentle physical activity as potential strategies for alleviating discomfort.

Beclot 500mg/250mg Tablet MR Side Effects

• Nausea
• Vomiting
• Heartburn
• Indigestion
• Diarrhea
• Loss of Appetite
• Nasal congestion (stuffy nose)
• Headache
• Tiredness
• Musculoskeletal (bone, muscle or joint) pain
• Anemia (low number of red blood cells)
• Stomach Pain
• Sinus Pain
• Sinus Inflammation

How to use Beclot 500mg/250mg Tablet MR

Take this medication according to the prescribed dosage and period recommended by your physician. Consume it in its entirety. It is advised to refrain from masticating, pulverizing, or fracturing the object in question. The administration of Beclot 500mg/250mg Tablet MR should be accompanied by the consumption of food.

FAQs

Q1. What is the composition and purpose of Beclot 500mg/250mg Tablet MR?

The medication known as Beclot 500mg/250mg Tablet MR comprises a mixture of two active substances, namely Tranexamic Acid and Mefenamic Acid. This drug is indicated for the management of discomfort and the treatment of excessive menstrual bleeding in women throughout their monthly menstrual cycles.

Q2. Are there any particular contraindications linked to the administration of Beclot 500mg/250mg Tablet MR?

Indeed, the administration of this substance is deemed detrimental to individuals afflicted with advanced renal insufficiency, ongoing intravascular coagulation, and impairments in color perception.

Q3. What are the recommended storage conditions for Beclot 500mg/250mg Tablet MR?

It is advisable to store this medication in its original container or packaging, ensuring that it is securely sealed. The storage should be conducted in accordance with the directions provided on the packaging or label. Properly discard the medication that is not being utilized. It is imperative to ensure that the product is not ingested by domestic animals, minors, or others other than the intended user.